Lathrop, Kate Ida | Faculty Directory

Professional Background

Education

2014 - Clinical Fellowship - Medical Oncology and Hematology - University of Texas Health Science Center at San Antonio
2011 - Residency - Chief Resident - University of Texas Health Science Center at San Antonio, San Antonio, TX
2010 - Residency - Internal Medicine - University of Texas Health Science Center at San Antonio
2008 - Postdoctoral Training - Internal Medicine - University of Texas Health Science Center at San Antonio
2007 - MD - Medicine - University of Texas Health Science Center at San Antonio
2002 - BA - Biology - Colorado College

Appointments

7/2017 - Program Director Hematology Oncology Fellowship Program - UT Health San Antonio MD Anderson Cancer Center, Medicine, San Antonio
8/2015 - Medical Director Hematology Oncology - University Health SystemSan Antonio
8/2014 - Assistant Professor - UT Health San Antonio MD Anderson Cancer Center, Medicine, San Antonio

Instruction & Training

Research & Grants

Clinical

Board Certifications

- American Board of Internal Medicine/Medical Oncology

- American Board of Internal Medicine

Publications

Abstract

Lathrop KI. A phase 2 study of poziotinib in patients with HER2-positive metastatic breast cancer (MBC) who have received prior HER2 regimens for MBC; 2016 Dec. Lathrop KI. Adequacy of breast screening in women previously treated with chest wall radiation for lymphoma; 2016 Nov. Lathrop KI. 2017 Cancer Survivorship Symposium; 2016 Nov. Lathrop KI. Ribociclib (LEE011) and Letrozole in ER+, HER2- Advanced Breast Cancer: Phase lb Safety, Preliminary Efficacy, and Molecular Analysis"; 2016 Sep. Lathrop KI;Juric D, Ismail-Khan R, Campone M, Garcia-Estevez L, Becerra C, De Boer R, Hamilton E, Mayer IA, Hui R, Lathrop KI, Pagani O, Asano S, Bhansali SG, Zhang V, Hewes B, Munster P. [P3-14-01] Phase Ib/II study of ribociclib and alpelisib and letrozole in ER , HER2? breast cancer: Safety, preliminary efficacy and molecular analysis: Kate Lathrop; 2015 Dec.

Editorial

Lathrop KI. Highlights from 2015 San Antonio Breast Cancer Symposium Highlights from 2015 San Antonio Breast Cancer Symposium 2015 Dec;:1-20.

Journal Article

Parsons HM, Lathrop KI, Schmidt S, Mazo-Canola M, Trevino-Jones J, Speck H, Karnad AB. Breast cancer treatment delays in a majority minority community: is there a difference? J Oncol Pract 2015 Mar;11(2):144-153.

Not Specified

Lathrop KI. New Note from Copeland Edward, Chapter 79: Unknown Primary Presenting with Axillary Lymphadenopathy, Bland et al The Breast, 5th edition 2016 Jun;.

Kate I Lathrop, MD

Education

Appointments